ethyl 5-oxo-1H,5H-pyrazolo[1,5-a]quinazoline-3-carboxylate, 98%, 100mg

5-Fluoro-6-methylnicotinonitrile, 95%, 1g

2-Chloro-3-(chloromethyl)quinoline, 95.0%, 1g

2-(3-(Trifluoromethyl)phenyl)ethanol, 95.0%, 5g

Nonyl Acetate>99.0%(GC)500mL

4-Bromo-3-ethylaniline, 94.0%, 10g

Sulfamic acid, 6,7,8,9,10,11-hexahydro-6-oxobenzo[b]cyclohepta[d]pyran-3-yl ester, 98%, 250mg

6-Methoxy-2-methyl-1H-benzo[de]isoquinoline-1,3(2H)-dione, 95.0%, 25g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 5mg

2,4-Dichloro-5-fluoro-3-nitrobenzoic acid, 97.0%, 5g

8-(2-PROPENYLOXY)-1,4-DIOXASPIRO[4.5]DECANE, 95.0%, 1g

L-kynurenine, min 98%, for biochemistry, 250 mg, glass packaging

3-amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrate, 95.0%, 10g